Skip to main content

Free Drug Lords 2025: Version 1 (Terminal Edition)

Free Drug Lords 2025: Version 1 (Terminal Edition) Game Cover

Platforms

Windows
Free Drug Lords 2025: Version 1 (Terminal Edition) Game Cover

About Free Drug Lords 2025: Version 1 (Terminal Edition)

Free Drug Lords 2025: Version 1 (Terminal Edition) is a single player simulation game with a business theme. It was developed by ThePlugForGames and was released on May 6, 2025.

Classic Drug Dealing Strategy — Rebuilt for 2025 Welcome to Drug Lords 2025: Version 1 — a faithful throwback to the original street simulation games of the 90s, reimagined in a sleek terminal-style format. This lightweight .exe game throws you into the high-stakes grind of underground business where buy low, sell high, and avoid the heat is the only way to survive. Key Features:  Start with …

Skip Games Like Free Drug Lords 2025: Version 1 (Terminal Edition)

Games Like Free Drug Lords 2025: Version 1 (Terminal Edition)

Looking for games like Free Drug Lords 2025: Version 1 (Terminal Edition)? Here are top simulation recommendations with a business focus, selected from player-similarity data — start with Free Drug Lords 2025: Version 2 – Terminal Strategy Redefined, Super Sanctum TD or Dead Pixels.

Skip Game Offers

Buy Free Drug Lords 2025: Version 1 (Terminal Edition)

Skip FAQs

Frequently Asked Questions

Free Drug Lords 2025: Version 1 (Terminal Edition) is a simulation game with business theme. Common tags for Free Drug Lords 2025: Version 1 (Terminal Edition) include indie, addictive and funny.

Free Drug Lords 2025: Version 1 (Terminal Edition) is available on Windows.

Free Drug Lords 2025: Version 1 (Terminal Edition) was released on May 6, 2025.

Free Drug Lords 2025: Version 1 (Terminal Edition) was developed by ThePlugForGames.

Free Drug Lords 2025: Version 1 (Terminal Edition) is a single player game.

Similar games include Free Drug Lords 2025: Version 2 – Terminal Strategy Redefined, Super Sanctum TD, Dead Pixels, SnakeIO, Drug Dealer Simulator and others.